Viekira
Drug
AbbVie, Inc.
Total Payments
$2.5M
Transactions
12,101
Doctors
4,437
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $32,500 | 16 | 1 |
| 2018 | $8,999 | 145 | 90 |
| 2017 | $2.5M | 11,940 | 4,408 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.2M | 457 | 49.3% |
| Consulting Fee | $534,750 | 209 | 21.2% |
| Food and Beverage | $309,926 | 10,432 | 12.3% |
| Travel and Lodging | $190,758 | 869 | 7.6% |
| Unspecified | $166,769 | 5 | 6.6% |
| Space rental or facility fees (teaching hospital only) | $75,600 | 29 | 3.0% |
| Education | $2,001 | 100 | 0.1% |
Payments by Type
General
$2.4M
12,096 transactions
Research
$166,769
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A15-491 | AbbVie, Inc. | $166,638 | 0 |
Top Doctors Receiving Payments for Viekira — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD, MPH, FACP | Hepatology | Philadelphia, PA | $20,523 | 26 |
| , M.D | Internal Medicine | Baltimore, MD | $18,402 | 20 |
| , MD | Transplant Hepatology | Atlanta, GA | $18,164 | 30 |
| Nigahus Karabulut | — | Ewing, NJ | $18,105 | 25 |
| , M.D | Hospitalist | Augusta, GA | $17,721 | 28 |
| , M.D | Nephrology | Macon, GA | $17,317 | 32 |
| , M.D | Gastroenterology | Fayetteville, NC | $16,672 | 23 |
| , MD | Infectious Disease | Miami, FL | $15,811 | 41 |
| Vinay Sundaram | — | Los Angeles, CA | $15,363 | 18 |
| , MD | Gastroenterology | Pittsburgh, PA | $14,937 | 24 |
| , MD | Gastroenterology | Brooklyn, NY | $14,149 | 31 |
| , MD | Gastroenterology | Manhasset, NY | $14,125 | 14 |
| , MD | Internal Medicine | Brooklyn, NY | $14,117 | 23 |
| , MD | Gastroenterology | Seattle, WA | $13,555 | 25 |
| , MD | Internal Medicine | New York, NY | $13,463 | 29 |
| , M.D | Gastroenterology | Washington, DC | $13,438 | 13 |
| , MD | Transplant Hepatology | Philadelphia, PA | $12,978 | 23 |
| , MD | Hepatology | Houston, TX | $12,933 | 23 |
| , M.D | Gastroenterology | Phoenix, AZ | $12,797 | 33 |
| , MD | Gastroenterology | San Francisco, CA | $12,666 | 3 |
| , MD | Gastroenterology | Burr Ridge, IL | $12,565 | 34 |
| , MD | Internal Medicine | Charlotte, NC | $12,385 | 12 |
| , M.D | Family Medicine | Sterling, IL | $12,350 | 1 |
| , MD | Gastroenterology | Maitland, FL | $12,144 | 21 |
| , MD, MPH | Gastroenterology | Dallas, TX | $11,736 | 9 |
Ad
Manufacturing Companies
- AbbVie, Inc. $2.5M
- AbbVie Inc. $32,500
Product Information
- Type Drug
- Total Payments $2.5M
- Total Doctors 4,437
- Transactions 12,101
About Viekira
Viekira is a drug associated with $2.5M in payments to 4,437 healthcare providers, recorded across 12,101 transactions in the CMS Open Payments database. The primary manufacturer is AbbVie, Inc..
Payment data is available from 2017 to 2019. In 2019, $32,500 was paid across 16 transactions to 1 doctors.
The most common payment nature for Viekira is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.2M, 49.3% of total).
Viekira is associated with 1 research study, including "A15-491" ($166,638).